<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0000855'>Insulin resistance</z:hpo> in Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> leads to <z:hpo ids='HP_0001397'>hepatic steatosis</z:hpo> that can accompanied by progressive <z:mp ids='MP_0001845'>inflammation</z:mp> of the liver </plain></SENT>
<SENT sid="1" pm="."><plain>Citrus unshiu peel is a rich source of citrus <z:chebi fb="5" ids="47916">flavonoids</z:chebi> that possess anti-inflammatory, anti-diabetic and <z:chebi fb="23" ids="18059">lipid</z:chebi>-lowering effects </plain></SENT>
<SENT sid="2" pm="."><plain>However, the ability of citrus unshiu peel <z:chebi fb="37" ids="16236,44730">ethanol</z:chebi> extract (CPE) to improve <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo>, <z:e sem="disease" ids="C0028754" disease_type="Disease or Syndrome" abbrv="">adiposity</z:e> and <z:hpo ids='HP_0001397'>hepatic steatosis</z:hpo> in Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> is unknown </plain></SENT>
<SENT sid="3" pm="."><plain>Thus, we evaluated the effects of CPE on markers for <z:chebi fb="105" ids="17234">glucose</z:chebi>, <z:chebi fb="23" ids="18059">lipid</z:chebi> metabolism and <z:mp ids='MP_0001845'>inflammation</z:mp> in Type 2 diabetic mice </plain></SENT>
<SENT sid="4" pm="."><plain>Male C57BL/KsJ-db/db mice were fed a <z:mpath ids='MPATH_458'>normal</z:mpath> diet with CPE (2 g/100 g diet) or <z:chebi fb="0" ids="50122">rosiglitazone</z:chebi> (0.001 g/100 g diet) for 6 weeks </plain></SENT>
<SENT sid="5" pm="."><plain>Mice supplemented with the CPE showed a significant decrease in body <z:mp ids='MP_0005456'>weight gain</z:mp>, body fat mass and blood <z:chebi fb="105" ids="17234">glucose</z:chebi> level </plain></SENT>
<SENT sid="6" pm="."><plain>The antihyperglycemic effect of CPE appeared to be partially mediated through the inhibition of hepatic gluconeogenic <z:chebi fb="0" ids="18021">phosphoenolpyruvate</z:chebi> carboxykinase <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression and its activity and through the induction of insulin/glucagon secretion </plain></SENT>
<SENT sid="7" pm="."><plain>CPE also ameliorated <z:hpo ids='HP_0001397'>hepatic steatosis</z:hpo> and <z:hpo ids='HP_0002155'>hypertriglyceridemia</z:hpo> via the inhibition of gene expression and activities of the lipogenic enzymes and the activation of fatty acid oxidation in the liver </plain></SENT>
<SENT sid="8" pm="."><plain>These beneficial effects of CPE may be related to increased levels of anti-inflammatory adiponectin and interleukin (IL)-10, and decreased levels of pro-inflammatory markers (IL-6, monocyte chemotactic protein-1, interferon-γ and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-α) in the plasma or liver </plain></SENT>
<SENT sid="9" pm="."><plain>Taken together, we suggest that CPE has the potential to improve both <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> and <z:hpo ids='HP_0001397'>hepatic steatosis</z:hpo> in Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>